[Remote] Executive Director, Global Value, Access and Pricing, NSCLC

Note: The job is a remote job and is open to candidates in USA. Revolution Medicines is a clinical-stage precision oncology company focused on developing novel targeted therapies for RAS-addicted cancers. The Executive Director will lead the development and execution of global market access and pricing strategies for NSCLC, collaborating with various teams to ensure optimal access and reimbursement outcomes across all regions. Responsibilities • Formulate and define asset and disease area pricing and reimbursement strategies to support optimal access and reimbursement outcomes across all target regions. This includes asset global pricing architecture and launch sequencing strategy to develop net price corridors, reference pricing and value-based designs • Craft a differentiated global value proposition and oversee the development of the Global Value Dossier (GVD) and payer negotiation materials • Work closely with members of the Disease Area Strategy teams to help shape priority clinical development plans and combinations with both RevMed and oncology combination therapy opportunities • Design and implement strategic plans to support clinical development programs to ensure study designs, endpoints, and analyses generate the evidence needed for payer and HTA submissions including seeking systematic HTA advice • Identify and assess global market access risks and opportunities, integrating them into product strategies and reflecting them in Target Product Profiles (TPPs) • Partner with Clinical Development and Regulatory Affairs to incorporate payer and patient relevant evidence into clinical development strategies • Collaborate closely with the HEOR team to ensure alignment between market access needs and health economic research plans for pipeline assets • Engage with Regions to incorporate payer, policy insights and global trends into product access strategy • Lead global payer research and work with regions to gain actionable early engagement/advice from key HTA bodies (e.g., G-BA, NICE, HAS, AIFA, Chuikyo) • Develop and maintain strong business relationships with key functions responsible for value proposition enablement with a focus on Clinical, Commercial, Regulatory, Medical Affairs, and HEOR stakeholders • Prepare and submit HTA and reimbursement dossiers in priority markets with clear alignment to clinical and economic evidence plans • Partner with Medical Affairs, HEOR, Regulatory, and Clinical to align evidence generation with access and reimbursement needs • Build strong cross-funtional relations and build a high-performing team that coordinates closely with regional leads and country affiliates • Serve as a key leader within the global launch team, actively contributing to go-to-market planning, demand forecasting, and gross-to-net-scenario modeling • As required, represent the company externally with payers, HTA bodies, trade associations, and policy groups, helping shape access environments • Coordinate with the U.S. region to align on policy and legislation risks that could impact life cycle management pricing corridors Skills • Bachelor's degree required; advanced degree in Pharmacy, Health Economics, Public Health, Life Sciences, or Business preferred (e.g., PharmD, PhD, MBA) • Minimum 15+ years of progressive leadership in market access, pricing, and HEOR within the biopharma industry • Demonstrated success launching a first-in-class or specialty therapy in ex-U.S. markets (especially Germany, France, and Japan) • Demonstrating the ability to build a new capability and framework to support a Global Market Access commercialization strategy • Established network of relationships with key stakeholders and organizations in Global Market Access landscape • Experience engaging HTA and payer organizations in early advice to inform development and trial strategies • Deep understanding of global payer systems and HTA processes, including AMNOG, Chuikyo, NICE, and other EU frameworks • Experience designing and implementing global pricing strategy, including value-based pricing, launch sequencing, and reference pricing mitigation • Proven ability to work cross-functionally and influence executive leadership in a dynamic, resource-constrained, early-stage company • Prior experience with Ex-U.S. and U.S. legislation and public policies that impact Global and regional decisions (U.S. IRA, MFN, EU regulations etc.) • Familiarity with rare disease, or oncology product launches • Experience working with external vendors, consultants, and access agencies to develop payer research, modeling, and dossier development • Strong executive presence, with the ability to clearly articulate complex value stories to both internal and external stakeholders • Experience building or scaling global market access functions in a pre-commercial or newly commercial biotech company Benefits • Competitive cash compensation • Robust equity awards • Strong benefits • Significant learning and development opportunities Company Overview • Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists. It was founded in 2015, and is headquartered in Redwood City, California, USA, with a workforce of 501-1000 employees. Its website is Company H1B Sponsorship • Revolution Medicines has a track record of offering H1B sponsorships, with 9 in 2025, 18 in 2024, 15 in 2023, 8 in 2022, 1 in 2021, 2 in 2020. Please note that this does not guarantee sponsorship for this specific role. Apply tot his job